Emcure Appoints C S Muralidharan Independent Director

Emcure Pharmaceuticals appoints Mr. C S Muralidharan as Independent Director for a 3-year term effective April 1, 2026.
Appointment approved via postal ballot e-voting concluded on April 24, 2026, with results announced on April 27, 2026.
Regulatory intimation confirms director meets SEBI eligibility criteria and has no familial relations with company leadership.